Evaluating the impact of a training-and-communication network program in nephrology to facilitate the detection and management of drug-related problems by community pharmacists.

Not Applicable

Recruiting

• Conditions: Chronic kidney disease; Renal and Urogenital - Kidney disease

• Registration Number: ACTRN12610001088033
• Lead Sponsor: Canadian Institutes of Health Research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-12-13
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 454

Inclusion Criteria

Patients: 1) have moderate (GFR: 30-59 ml/min/1.73 m2) or severe (GFR: 15-29 ml/min/1.73 m2) CKD based on the last laboratory test result performed; 2) are at least 18 years old; and 3) speak and read French or English; 4) have a eligible current community pharmacy that agrees to participate; 5) agree to continue being followed by their current community pharmacy for the duration of the study; and 6) are able to understand the study and provide informed consent. Patients will be excluded if they have a GFR < 15 ml/min/1.73 m2 or >59 ml/min/1.73 m2. Community pharmacy: 1) for pharmacies delivering >250 prescriptions per day: at least 60 hours are covered by participating pharmacists; OR for pharmacies delivering = 250 prescriptions per day at least 35 hours are covered by participating pharmacists; OR for pharmacies opened less than 7 days a week at least 50% of the opening hours are covered by participating pharmacists; 2) a pharmacist agrees to become in charge of the project in his/her pharmacy; 3) all participating pharmacists agree to complete the training program if assigned to the ProFiL group; 4) pharmacists agree to keep a copy of all pharmaceutical opinions issued during the study and to provide a copy of the patients’ pharmacy chart for the period covering the 12 months prior and after the baseline; 5) pharmacists working in more than one participating pharmacies agree to be assigned to the pharmacy where he/she is working most of the time; 6) a pharmacy can not recruit more than 20 patients. Finally, each participating pharmacy can only be randomized once.

Exclusion Criteria

patients with a GFR less than 15ml/min/1,73m2 or more than 59ml/min/1,73m2 having dialysis at enrollment. All patients not fulfilling the inclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Compare the mean change in the number of highly relevant DRPs per patient, as defined by the PAIR criteria.[Between the baseline and the month-12 evaluations in ProFiL and UC patients.]